GATC Biotech’s INVIEW TRANSCRIPTOME ISOFORM DISCOVER establishes a new quality standard for all isoform-related research
Oncomine Cell-Free DNA Assay is designed to target and detect mutations down to 0.1 percent allele frequencies from whole blood derived from lung cancer tumors
Niguarda Hospital, Milan, shares experiences in newly available case study
Project that measured pathogens in New York City subways goes global this summer
New follow-up assay helps stratify patients with transforming HPV infections
Liquid biopsy test from GATC Biotech offers non-invasive analysis of 12 actionable genomic alterations in circulating cell-free DNA
NIGHTSEA proudly announces the1000th installation of its Model SFA Stereomicroscope Fluorescence Adapter
Key opinion leaders’ expertise to guide design of new gene panels for GeneReader NGS
Actionable Insights Tumor Panel enables monitoring of cancer biomarkers from plasma samples
Future joint collaborations are expected as work continues to unlock the full clinical and research potential of both technologies
Reference data set from Horizon affirms proven accuracy of GeneReader workflow
Studies demonstrate pioneering research possible using ChIP technology
Horizon’s X-MAN cell lines to be made available in conjunction with Ubiquigent’s ubiquitin-related Drug Discovery Services
34-gene panel for assessing risk of 15 inherited cancers among new Quest Vantage™ test services to be highlighted during the 2016 ASCO Annual Meeting
Chromatrap® has announced a new 96-well high throughput purification plate for production of ultra-pure DNA
Siemens Healthineers will expand its portfolio with molecular testing related services and technologies for oncology and genomics
Direct comparative studies now possible with a set of cancer-specific genes for DNA from tumor tissue or for circulating tumor DNA from liquid biopsy samples
